Received Jul 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2HJ99 | — |
Shingrix + Adjuvant administration only; Incorrect dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number 2HJ99, expiry date 04-APR-2027) for prophylaxis. On 07-JUL-2025, the patient received Shingrix. On 07-JUL-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix + Adjuvant administration only) and inappropriate dose of vaccine administered (Verbatim: Incorrect dose administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 07-JUL-2025 Nurse reported that a patient received the Adjuvant portion only of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not consent to follow-up. The Vaccine Administration Facility is the same as Primary Reporter.